Dr. Mark Ware is Associate Professor in Family Medicine and Anesthesia at McGill University. He is the Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre, co-Director of the Quebec Pain Research Network, and Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids (CCIC). He is a family physician and practices pain medicine at the Montreal General Hospital and at the primary care pain clinic of the West Island of Montreal.
Dr Ware’s primary research interests are in evaluating the safety and effectiveness of medicines derived from cannabis (cannabinoids), population-based studies of the impact of pain on the population, and the role of complementary therapies in pain and symptom management. His research is funded by the Arthritis Society, ALS Canada, the Canadian HIV Trials Network, FRSQ, CIHR, and the Louise and Alan Edwards Foundation.
A graduate of the University of the West Indies (MBBS 1992), Dr. Ware worked at the MRC Sickle Cell Unit in Kingston Jamaica from 1996-1998 where he developed his interests in pain management and cannabis therapeutics. He moved to McGill University in Montreal, Canada in 1999 and since then secured the only two Canadian federal grants to study medical cannabis. He has published over 90 papers on pain and cannabis, 6 book chapters, and given over 200 scientific talks to local, national and international audiences. He has served as an advisor to the Canadian government since 2001 on medical cannabis policy, most recently as vice Chair of the Federal Task Force on the legalization and regulation of cannabis in Canada.